← back to search

Janis A. Müller

University Hospital Ulm · BR
Area of research
Infectious Diseases · Obstetrics and Gynecology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, COVID-19 Impact on Reproduction, and interferon and immune responses.
h-index
35
citations
4,820
works
88
NIH funding
primary concept
Biology
email

Recent publications

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.
2024cited by 2,671position: contributordoi
Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens
Nature Microbiology 2024cited by 46position: lastdoi
Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens.
2024cited by 25position: contributordoi
Lipid A in outer membrane vesicles shields bacteria from polymyxins
Journal of Extracellular Vesicles 2024cited by 17position: middledoi
Lipid A in outer membrane vesicles shields bacteria from polymyxins.
2024cited by 15position: contributordoi
Determinants of species-specific utilization of ACE2 by human and animal coronaviruses.
2023cited by 13position: contributordoi
The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties.
2023cited by 6position: contributordoi
Suitable Disinfectants with Proven Efficacy for Genetically Modified Viruses and Viral Vectors.
2023cited by 2position: contributordoi
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
2022cited by 110position: contributordoi
Robust and durable serological response following pediatric SARS-CoV-2 infection.
2022cited by 63position: contributordoi
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
2022cited by 26position: contributordoi
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture
Communications Biology 2022cited by 25position: middledoi
Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.
2022cited by 20position: contributordoi
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults.
2022cited by 18position: contributordoi
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture.
2022cited by 16position: contributordoi
Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2.
2022cited by 10position: contributordoi
Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses.
2022cited by 10position: contributordoi
Virucidal activity of SARS-CoV-2 rapid antigen extraction buffers.
2022cited by 4position: contributordoi
Utilization of Aminoguanidine Prevents Cytotoxic Effects of Semen.
2022cited by 3position: contributordoi
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Nature Metabolism 2021cited by 563position: firstdoi
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas.
2021cited by 398position: contributordoi
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.
2021cited by 207position: contributordoi
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
Nature Communications 2021cited by 189position: middledoi
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
2021cited by 162position: contributordoi
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Nature Communications 2021cited by 132position: middledoi
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection.
2021cited by 114position: contributordoi
Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia.
2021cited by 105position: contributordoi
Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell-Derived Intestinal Organoids.
2021cited by 79position: contributordoi
Promoting and Protecting Human Milk and Breastfeeding in a COVID-19 World
Frontiers in Pediatrics 2021cited by 73position: middledoi
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures.
2021cited by 46position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Jan Münch · University Medical Center40 papers (2014–2024)Konstantin M. J. Sparrer · University of Chicago15 papers (2019–2024) · 14 papers (2019–2024)Frank Kirchhoff · Kirchhoff (Germany)13 papers (2020–2024) · 12 papers (2019–2024) · 10 papers (2021–2024) · 7 papers (2020–2024)Alexander Kleger · Molecular Oncology (United States)6 papers (2020–2021) · 6 papers (2020–2021)Tatjana Weil · University Medical Center6 papers (2020–2022)Frank Kirchhoff · Kirchhoff (Germany)5 papers (2014–2020)Warner C. Greene · Gladstone Institutes4 papers (2014–2017)Nadia R. Roan · Gladstone Institutes4 papers (2014–2017)Stefan Pöhlmann · University of Göttingen4 papers (2021–2024)Daniel Sauter · Institute of Medical Microbiology and Hygiene4 papers (2020–2021) · 4 papers (2021–2021)Lukas Wettstein · Universitätsklinikum Ulm4 papers (2021–2022)Markus Hoffmann · German Primate Center4 papers (2021–2024) · 3 papers (2014–2014)Meta Volcic · Universität Ulm3 papers (2021–2021)